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ABSTRACT 
Introduction 
Self-management and remaining physically active are first-line recommendations for the care of 
patients with low back pain (LBP). With a life-time prevalence of up to 85%, novel approaches 
to support behavioural self-management are needed. Internet interventions may provide 
accessible support for self-management of LBP in primary care. The aim of this randomised 
controlled trial is to determine the clinical and cost-effectiveness of the ‘SupportBack’ internet 
intervention, with or without physiotherapist telephone support in reducing LBP-related 
disability in primary care patients.  
 
Methods and analysis 
A three parallel arm, multi-centre randomised controlled trial will compare three arms: 1) usual 
primary care for LBP; 2) usual primary care for LBP and an internet intervention; 3) usual 
primary care for LBP and an internet intervention with additional physiotherapist telephone 
support. Patients with current LBP and no indicators of serious spinal pathology are identified 
and invited via general practice list searches and mailouts or opportunistic recruitment following 
LBP consultations. Participants undergo a secondary screen for possible serious spinal 
pathology and are then asked to complete baseline measures online after which they are 
randomised to an intervention arm. Follow-ups occur at six weeks, three, six and 12 months. 
The primary outcome is physical function (using the Roland and Morris Disability 
Questionnaire] over 12-months [repeated measures design). Secondary outcomes include pain 
intensity, troublesome days in pain over the last month, pain self-efficacy, catastrophising, 
kinesophobia, health-related quality of life and cost-related measures for a full health economic 
analysis. A full mixed methods process evaluation will be conducted.  
 
Ethics and dissemination 
This trial has been approved by an NHS Research Ethics Committee (REC Ref: 18/SC/0388). 
Results will be disseminated through peer-reviewed journals, conferences, communication with 
practices and patient groups. Patient representatives will support the implementation of our full 
dissemination strategy. 
 
Trial registration number: ISRCTN reference 14736486 (pre-results) 
Key words: Low Back Pain; Internet Intervention; Primary Care; Randomised Controlled Trial 
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STRENGHTS AND LIMITATIONS 
 
• The SupportBack 2 trial is a large multi-centre randomised trial that will determine the 
additional benefit, over usual primary care, of an internet-based approach that supports 
self-management of patients with LBP in UK primary care. 
• The trial is designed to investigate the effectiveness of an internet intervention in 
addition to usual primary care, both with and without telephone physiotherapist support. 
• A full mixed methods process evaluation will be carried out to inform a logic model and 
‘theory of change’ for the interventions. 
• Inclusion is limited to those with LBP who have access to the internet and are able to 
communicate in English without assistance.  
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INTRODUCTION 
Low Back Pain (LBP) has a life-time prevalence of up to 85% [1] and is the greatest single 
cause of years lived with disability globally. [2] LBP is primarily managed in primary care, [3] 
where first-line recommendations are to self-manage and remain physically active. [4] 
Supporting effective behavioural self-management of LBP is increasingly important; the most 
recent guidelines place less emphasis on pharmacological and surgical treatments. [5] General 
practitioners are unlikely to have the training or the capacity to support behavioural self-
management, and access to specialist musculoskeletal (MSK) services can be variable. [6] New 
roles such as First Contact Physiotherapists in general practice are emerging, but 
implementation is at an early stage. [7]  Internet interventions may offer a route to rapidly 
scalable behavioural support for patients with LBP, however their effectiveness in UK primary 
care needs to be determined.  
Internet interventions are typically automated, interactive, tailored interventions that make use 
of multimedia formats to deliver behaviour change strategies online. [8] Internet interventions 
are one form of a broader category of digital interventions that draw on digital technologies 
including the internet, mobile devices and activity sensors. [9] A recent systematic review of 
digital interventions for LBP highlighted substantial heterogeneity in intervention delivery, 
duration and outcomes, making it difficult to draw conclusions regarding effectiveness. [10] 
Since the publication of this review there has been a focus on mobile apps for LBP: a German 
study has shown that a mobile app delivering multidisciplinary self-management support for 
patients with LBP recruited via online advertising significantly reduced pain at 12-week follow-
up, compared to a 6-week course of exercise delivered by physiotherapists plus online 
education. [11] An ongoing European programme of work seeks to determine the effectiveness 
of a mobile app-based digital decision support self-management programme (selfBACK) for 
patients recently consulting in primary care for LBP. [12] Whilst mobile apps show potential, 
internet interventions likely have an accessibility advantage; they can be accessed from any 
device with an internet connection (e.g. desktop, laptop, tablet, mobile phone).  
SupportBack is an internet intervention designed to support patients to self-manage their LBP 
following consultation in primary care. [13, 14] It was developed using evidence and theory in 
combination with the person-based approach, where systematic qualitative research is integrated 
throughout development. [15, 16] SupportBack is designed to be as accessible as possible, both 
in presentation style and in target; it can be used by people with both acute and persistent LBP.  
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SupportBack has been developed to be used in addition to usual care, either as a stand-alone 
internet intervention or in combination with physiotherapist telephone support. A randomised 
controlled feasibility trial demonstrated both the feasibility of trial procedures and the effective 
delivery of the intervention and telephone support. [14] In a nested qualitative study within the 
feasibility trial, Geraghty et al. [15] found that patients were broadly positive about the 
intervention; they suggested that it provided reassurance whilst supporting becoming more 
physically active as a primary pain management strategy.   
The aim of the present full randomised controlled trial is to determine the clinical and cost-
effectiveness of the SupportBack internet intervention, delivered in addition to usual care with 
and without physiotherapist telephone support, in reducing LBP-related physical disability in 
UK primary care.  
 
METHODS 
Design 
A three parallel arm (1:1:1), multicentre randomised controlled trial is being conducted to 
determine the clinical and cost-effectiveness of an internet intervention for patients with LBP in 
primary care. Participants will be followed up at six weeks, three, six and 12 months.  
 
Study setting 
The trial is being carried out with patients from 140-180 general practices across the UK. 
Patients access the intervention through their own devices with internet access (e.g. a desktop, 
laptop, tablet, mobile phone) at a location that is convenient for them (e.g. at home or at work). 
If allocated to receive telephone physiotherapist support, this support is delivered wherever is 
convenient for the patient. A list of patient identification centres is available from the trial team 
on request.  
 
Eligibility criteria 
 
Inclusion criteria: 
• Aged 18 and above 
• Current low back pain (have experienced pain in the last week) with or without sciatica 
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• Access to the internet and an active email address 
• Ability to read/understand English without assistance 
• Ability to provide informed consent 
 
Exclusion criteria: 
• Signs and symptoms in a patient with LBP that indicate potential serious spinal pathology 
such as infection, malignancy, fracture, inflammatory back pain, progressive neurology 
and/or cauda equina. 
• Have had spinal surgery in the past six months 
• Pregnancy 
• Taken part in the prior SupportBack feasibility study 
 
Identification, recruitment and screening   
Two recruiting centres, Southampton and Keele [each with a team of telephone support 
physiotherapists] are working with National Institute for Health Research (NIHR) Clinical 
Research Networks (CRNs) to facilitate the recruitment of general practices.  Potentially eligible 
participants will be identified in one of two ways:  
 
1) Patients who have consulted with LBP in the last two months will be identified by 
general practice staff from computerised records of consultations.  Practices will be 
asked to repeat the searches approximately three times, or until the target number of 
patients per practice has been reached. Resulting lists of patients identified by the 
search will be screened by a practice GP who will rule out patients based on aspects 
of the eligibility criteria that can be determined from patient notes.   
 
2) During a patient consultation and on entering a relevant diagnostic or symptom Read 
code into the patient electronic medical record, GPs will be prompted about the trial 
and patient eligibility by an automated ‘pop-up’ screen activated by the Read code. 
GPs will then screen for eligibility [using the inclusion/exclusion criteria listed] and 
patients identified as suitable will have their medical record electronically tagged. A 
download of ‘tagged’ patients will occur regularly, anticipated to be every two 
weeks. This method will be used in practices where possible. Participating general 
practices not implementing the ‘pop up’ Read code method can identify potential 
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patients during consultation. Having considered eligibility the GP or Nurse 
Practitioner will provide the patient with an invitation pack. 
 
Patients identified either by a medical records review or general practice consultation are mailed 
a study pack including an invitation letter from the GP, participant information sheet, reply slip, 
screening questions and pre-paid envelope. Interested patients return the reply slip and screening 
questions using the pre-paid envelope to the Research Team.  Screening consists of two 
questions regarding current LBP and access to the internet, followed by three safety questions 
listing symptoms that may indicate serious spinal pathology.  Patients who answer ‘Yes’ to the 
first two questions, and ‘No’ to all safety questions, are considered eligible. For those who 
complete the screening questions and fail safety screening, a physiotherapist contacts the patient 
to make an appropriate clinical recommendation on hearing a further description of the 
symptoms. Those who fail the screening are documented on a screening log maintained by the 
Research Team.  All patients considered eligible for the trial are assigned a unique participant 
identification number and sent a link to the study website, to complete consent, baseline 
questionnaires and be randomised. Recruitment opened in November 2018 and is expected to 
close in December 2020, with data collection completing approximately 12 months later in 
December 2021.  
 
Randomisation, allocation and blinding 
The randomisation process for this trial is fully automated. The intervention and data collection 
software automatically generates the randomisation sequence, and a computer-generated 
algorithm block randomises participants to the trial groups. Participants are being stratified by 
trial recruiting centre and level of physical function: a score of less than four on the Roland 
Morris Disability Questionnaire (RMDQ [17]) is being used to denote a lower level of self-rated 
physical disability. As the automated software randomises patients, the randomisation sequence 
is concealed from the trial team. Patients are automatically informed of their group allocation 
through the internet intervention software. As patients are engaging with a behavioural 
intervention, they are not blind to allocation. The majority of data will be collected online, or by 
post. Telephone calls are used to collect primary outcome data where there has been no response 
to online and postal follow-up. The callers are blind to group allocation. The statisticians 
conducting the analyses will remain blind to group allocation. The health economist will 
conduct the majority of analysis blinded to group, however, estimates of total cost require the 
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addition of costs specific to the provision of the interventions so will become un-blinded at this 
point. Figure 1 details patient flow through the trial.  
 
[Insert Figure 1 about here] 
 
Interventions 
Usual care 
Participants randomised to this arm will continue to receive unrestricted usual primary care for 
LBP. Current NICE recommendations for primary care management of LBP suggest assessment 
to rule out specific spinal pathology and use of risk stratification tools (e.g. STarT Back [18]). 
Guidelines with regard to pharmacotherapy recommend NSAIDs at the lowest effective doses 
for the shortest period of time. Paracetamol and opiates are not recommended for routine use. 
Care may also include referrals for physiotherapy and psychological interventions such as 
cognitive behaviour therapy (CBT). Despite guidelines, there is likely to be a variety in what is 
provided for patients as part of usual care over the trial period from no further contacts, to 
referrals to physiotherapy and pain clinics. Consequently, health care resource use will be 
documented and form a central part of our health economic analysis.  
 
Usual care + Internet intervention 
Participants randomised to this arm will continue to receive unrestricted usual primary care. In 
addition, they will have access SupportBack. SupportBack is a multi-session, interactive internet 
intervention that provides participants with accessible information, advice and tools to support 
the effective self-management of LBP. The SupportBack intervention [including telephone 
support] has been extensively described elsewhere. [13, 15] In brief, the central components of 
the intervention include graded goal setting, self-monitoring, and tailored feedback to encourage 
physical activity/exercise increases or maintenance. SupportBack also provides educational 
modules regarding pain and LBP-related topics (relieving pain; flare ups; work; sleep; mood; 
daily living). Throughout the digital material, there is a focus on supporting motivation for 
behaviour change: Techniques employed include reassuring about consequences of movement, 
modelling of use of activity as a primary pain management strategy and using automation to 
deliver positive feedback through reassurance regarding consequences. These techniques were 
combined with a person-based approach in the development of SupportBack, where the 
application of such approaches was guided by systematic in-depth qualitative research with 
patients with LBP. [16] 
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Practically, patients can access SupportBack from any device with an internet connection from 
wherever is most convenient for them. SupportBack consists of six sessions, and patients are 
encouraged to log in and use one session per week. Automated reminders adhere to this 
schedule. The first session highlights the centrality of physical activity in managing LBP,  and 
supports patients to set goals to either walk more, or engage with a range of gentle back 
exercises of their choice. Goal options are tailored and are based the extent that patients report 
their LBP obstructs their day-to-day activities.  The further sessions feature self-monitoring and 
feedback regarding their progress with walking or exercise goals, combined with encouragement 
from SupportBack to continue. After the first session, patients can unlock one further module 
per week on topics such as sleep, mood and work. These build into a personal repository, that 
alongside weekly goals, can be accessed at any time. If engaged with weekly, the tailored, 
interactive part of the intervention will last six weeks. Following completion of all the sessions, 
SupportBack converts into static resource where all activities/exercises and modules can be 
accessed for the duration of the trial.  
 
Usual care + internet intervention + telephone physiotherapist support 
Participants randomised to this arm will also continue to receive unrestricted usual primary care, 
with access to the SupportBack internet intervention. In addition, these participants will also 
receive up to one hour of physiotherapist support over the telephone (the first call can be up to 
30 minutes, with two follow-up calls of up to 15 minutes, over the six-week intervention 
period). At both centres (Southampton and Keele) support is provided by musculoskeletal 
physiotherapists working in the NHS. 
 
The objectives of the telephone contact are to encourage the use of the SupportBack 
intervention, provide reassurance regarding LBP and encourage adherence to physical activity 
goals. The physiotherapists are asked to closely adhere to a standardised content checklist for 
each phone call. The checklist follows the CARE approach [19] (Congratulate, Ask, Reassure, 
Encourage), developed specifically to guide support for digital interventions. Drawing on 
existing clinical skills, it ensures a general supportive approach and requires minimal training 
(all support physiotherapists attended a two-hour training session ahead of the trial). Whilst 
telephone physiotherapists are able to address individual participant concerns, they are asked to 
avoid additional individualised participant assessment and treatment recommendations beyond 
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the internet intervention content. Physiotherapists complete a checklist for each call. Checklists 
are returned to the trial coordinating centre, where intervention fidelity will be assessed.  
 
 
Measures 
All measures and time points for collection are listed in Table 1.  
 
Primary outcome 
The primary outcome in this trial is LBP-related physical function measured with the Roland 
Morris Disability Questionnaire. [17] Function forms a central domain in the recommended core 
outcomes set for LBP trials. [20] The RMDQ is a recommended measure of physical function 
[21] and is commonly used in primary care LBP trials.  
 
Secondary measures 
Demographic data is being collected at baseline including age, sex, educational attainment, 
marital and occupational status. A range of secondary measures are being collected including 
pain intensity, [22] number of troublesome days in pain [23] and risk of pain related disability, 
[24] Pain-related psychological variables are being measured including kinesiophobia [fear of 
movement], [25] catastrophizing, [26] pain self-efficacy, [27] outcome expectations [28] and 
symptoms of depression and anxiety. [29] General physical activity is being measured with the 
Godin Leisure-time Exercise Questionnaire [30] in this trial; the short-form IPAQ [31] was used 
in the feasibility trial but produced unreliable data. We are also measuring intervention specific 
physical activity with a single item developed for this trial. Adherence to walking and physical 
activity goals are being measured with specifically developed items, based closely on measures 
previously used in a related behavioural trial [32] and difficulties with the intervention are being 
measured using the Problematic Experiences of Therapy Scale. [33]  
 
To support the health economic analysis health-related quality of life is being measured with the 
EQ-5D-5L. [34] All resources required to provide the internet intervention and the telephone 
support will be recorded. Details of NHS resource use will be recorded from general practice 
notes review. This will include both primary and secondary care contacts and will cover both 
general health care usage in addition to LBP specific care in the follow-up period. Additionally, 
LBP specific medication use will be captured. There may also be differences in LBP related 
services paid for by study participants: for example, complementary or alternative medicine 
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(CAM). Participants may also require time off work. Additionally, there may be under-reporting 
of LBP-specific resource use from medical records. These resources will be captured by means 
of a simple questionnaire administered at six and 12 months. The time-off work question and 
items relating to use of private health care will additionally be asked at baseline. All resources 
identified will be costed using appropriate local and national data, for example NHS reference 
costs and Unit Costs of Health and Social Care. Occupational status is being measured with a 
brief questionnaire developed for this trial. 
 
The internet intervention software automatically collects data on number of logins, page and 
module views and time spent in each login. This data will be used to explore adherence and user 
engagement to the digital component of the intervention.  
 
 
Table 1. Outcomes and measures used in the trial 
 
Domain 
 
Measure Time point 
Function (Primary outcome) 
LBP-related physical function Roland Morris Disability 
Questionnaire (RMDQ) [17] 
Baseline, 6 weeks, 3, 6, 12 
months. All arms. 
Pain 
Pain intensity Pain index (Numerical rating 
scales measuring current, 
average and least pain over the 
last 2 weeks) [22] 
Baseline, 6 weeks, 3, 6, 12 
months. All arms. 
Pain duration Time since last pain free month 
[35] 
Baseline. All arms. 
Troublesomeness of pain Troublesome days in pain over 
the last month [developed from 
days in pain measure [23] 
Baseline, 6 weeks, 3, 6, 12, 
months. All arms. 
Risk of persistent pain-related 
disability 
STarT Back tool [24] Baseline, 12 months. All arms. 
Psychological processes related to pain 
Fear of movement Tampa Scale for 
Kinesiophobia (TSK-11) [25] 
Baseline, 12 months. 
All arms. 
Catastrophising/negative 
orientation towards pain 
Pain Catastrophizing Scale 
(PCS) [26] 
Baseline, 12 months follow-up 
All arms. 
Confidence in ability to 
manage pain 
Pain Self-Efficacy 
Questionnaire (PSEQ) [27] 
Baseline, 6 weeks, 3, 6, 12 
months. All arms. 
Self-efficacy for managing 
LBP 
Single item from 
Musculoskeletal Health 
Questionnaire (MSK-HQ) [36] 
Baseline, 6 weeks, 3, 6, 12 
months. All arms. 
Outcome expectation Expectancy question from 
Credibility and Expectancy 
Baseline, all arms. following 
session one of SupportBack 
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Questionnaire modified for 
LBP CEQ low back pain 
modification [28, 37] 
Internet intervention arms only. 
Mental health Patient Health Questionnaire-4 
[29] depression and anxiety 
measure 
Baseline, 12 months. All arms. 
Physical activity/adherence 
General physical activity Godin leisure-time exercise 
questionnaire [30] 
Baseline, 12 months. All arms 
SupportBack-related physical 
activity 
Single item measure developed 
for the trial 
Baseline, 6 weeks, 3, 6, 12 
months. All arms. 
Adherence to back-specific 
activity 
Item developed for this trial, 
based on previous behavourial 
adherence measures [32] 
12 months. All arms 
Difficulties with intervention 
recommendations 
Problematic Experiences of 
Therapy Scale (PETS) [33] 
12 months.  
Internet intervention arms only. 
Satisfaction and enablement 
Satisfaction with care received 
for LBP 
Single satisfaction item 
developed for trial 
6 weeks. All arms.  
Enablement Patient Enablement Instrument 
(PEI) [38] 
6 weeks, 12 months. All arms. 
Health related quality of life, health care resource use, and occupational status 
Health-related Quality of Life ED-5D Five Level [34] Baseline, 6 weeks, 3, 6, 12 
months. All arms. 
Use of over-the-counter (OTC) 
medication for LBP 
Single item measuring self-
reported OTC medication 
usage for LBP 
Baseline, 6 months, 12 months. 
All arms. 
Participant borne costs Participant reported health 
resource use questionnaire 
developed for this study 
Baseline, 6 months, 12 months. 
All arms. 
NHS health care resource use 
(specific to back pain, and 
general) 
General practice medical notes 
review and Participant reported 
health care resource use 
questionnaire developed for 
this trial 
 
Baseline, 6 months, 12 months. 
All arms. 
Occupational impact of LBP  Brief occupational  
questionnaire developed for 
this trial.  
12 months. 
All arms. 
Use of internet resources 
Use of internet resources Single item regarding use of 
internet resources for LBP over 
trial period.  
12 months. 
All arms. 
 
 
Sample size 
The reported minimally clinical important difference (MCID) between groups for the RMDQ 
varies. A between group MCID of 2 or 3 points is commonly reported. [23, 39, 40] However, it 
has been suggested that a difference of 1.5 may still be important, particularly in the context of 
low intensity interventions. [23] Whether delivered as a stand-alone intervention or coupled 
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with brief telephone support, SupportBack is a low intensity intervention with the potential to be 
rapidly scalable. Consequently, we considered a between group change of at least 1.5 to be a 
meaningful difference in this context.  For our repeated measures primary outcome, a difference 
of 1.5 points on the RMDQ over the follow-up period of 12 months, assuming a standard 
deviation of 5 in line with the feasibility study, [23] gives an effect size of 0.30. Alpha will be 
set to 0.025 to allow both interventions to be independently compared with the usual care alone 
arm.  Using four repeated measures (six weeks, three, six and 12 months), and assuming a 
correlation between repeated measures of 0.7 and 90% power, requires 215 participants per arm. 
Allowing for 20% loss to follow up, this gives a total sample size of 806.   
 
Data collection and management 
Data are primarily being collected online.  The LifeGuide intervention and data system collects 
consent, baseline data including demographics and follow-up data across the four time points 
(six weeks, three, six and 12 months). When first sent a link to the system following screening, 
if patients do not log on within a week, they are emailed to check that they received the link and 
advised to look in their spam mail.  If there is no response, one telephone call is attempted by 
the research team. 
 
With regard to follow-up protocol, where there is no response to the online follow-up 
questionnaire emails, two reminder emails and text messages will be sent. Following continued 
non-response, a paper questionnaire pack with a pre-paid envelope will be sent one week after 
the last email/text reminder.  If the paper questionnaires are not returned within two weeks of 
being sent, a blinded research assistant will call the participant to complete the primary outcome 
measure (RMDQ), quality of life questionnaire (EQ-5D-5L) and pain severity. If the participant 
is happy to continue, further measures from the questionnaire battery at the respective follow-up 
point will be collected in this manner. The full follow-up protocol with the telephone calls will 
be implemented at six week and 12 month follow-up points. These two follow-up points are 
considered most important, capturing initial and long-term response. Calling at all time points 
may lead to increased dropout at later time points. Follow-up at three and six months will 
include all the above steps except for the phone calls. All participants will receive a £5 voucher 
when asked to complete questionnaires at the more distant time-points of six and 12 months. 
Examples of data collection forms can be provided by the trial team on request. 
 
Statistical methods 
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Quantitative analysis will begin following cleaning and inspection of the data. Descriptive 
analysis will be conducted to determine outliers and distributions of the data. Where necessary, 
if data are not normally distributed, transformations will be applied or another appropriate 
distribution used. The primary analysis for the RMDQ score will be performed using a 
multilevel mixed model (MLMM) framework with observations at six weeks, three, six and 12 
months (level one) nested within participants (level two).  Results will be reported adjusting for 
baseline severity in function, stratification factors and any pre-specified confounders.  The 
model will use all the observed data and makes the assumption that missing RMDQ scores are 
missing at random given the observed data.   
 
As there may not be a constant treatment effect over time, a treatment/time interaction will be 
modelled and included if significant (at the 5% level), with time treated as a random effect.  An 
unstructured covariance matrix will be used. 
 
Analysis of secondary outcomes will also be conducted using linear regression for continuous 
outcomes and logistic regression for dichotomous outcomes, again controlling for baseline 
symptom severity, stratification factors and any potential confounders. The structure and pattern 
of missing data will be examined, if appropriate, and a sensitivity analysis based on data 
imputed using a multiple imputation model presented. Data will be analysed on an intention-to-
treat basis [they will be analysed as randomised]. We will also undertake a complier-average 
causal effect (CACE) analysis, [41] which compares compliant participants in the intervention 
group, with those in the control group whose characteristics are similar enough to the 
intervention group compliers to suggest they too would have complied with the intervention, 
given the opportunity to do so. Compliance for these analyses in the intervention arm will be 
defined as completing at least Session 1 of the internet intervention. Session 1 contains the 
central rationale for the intervention; that physical activity is primary in the management of LBP 
and provides instructions and advice on goal setting. The latter sessions follow a similar format 
to the first introductory module. With regard to the physiotherapist telephone support arm, we 
consider per protocol to be receiving at least two of the three planned phone calls. The telephone 
element is designed to be pragmatic with the necessary flexibility to fit patients’ requirements. 
However, receiving at least two of three calls indicates that support was delivered over time; an 
important aspect in the design and integration with the internet intervention. 
 
It is not anticipated that there will be significant practice level [cluster] effects but this 
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assumption will be tested by comparing a fixed effect model to a random effects model. If there 
are significant practice level effects then, the model will include a random effect for practice 
[random intercept] and participant [random intercept and slope on time] to allow for between 
participant and practice differences at baseline and between participant differences in the rate of 
change over time (if significant at the 5% level), and fixed effects for baseline covariates. 
 
No interim analyses are planned.  Full details of the analyses to be undertaken will be set out in 
the Statistical Analysis Plan and approved by the Trial Steering Committee (TSC). Our full 
statistical analysis plan will be published on the trial website in due course 
(https://www.southampton.ac.uk/medicine/academic_units/projects/supportback2.page).  
 
Cost-effectiveness analysis 
A ‘within trial’ economic analysis will be conducted alongside the RCT to estimate the 
incremental cost-effectiveness of the SupportBack 2 interventions compared to usual care. The 
base case perspective will be that of the NHS, but other resources relevant to LBP will be 
collected to enable additional analysis from a societal perspective.  
 
The main outcome measure in the economic evaluation will be the quality adjusted life year 
(QALY), obtained from the EQ-5D-5L instrument using the published UK value set. In 
addition, a cost-effectiveness analysis will be carried out using the study primary outcome 
measure, i.e. the cost per point change in back-related physical function measured using the 
RMDQ will be estimated. Both costs and effects will be estimated using multiple regression, to 
allow for potential confounders, such as baseline scores for EQ-5D-5L and RMDQ. Standard 
practice will be followed to calculate incremental cost-effectiveness ratios (ICERs), and present 
ICER(s) where any one option has both higher costs and increased effects compared to another. 
ICERs will show incremental cost per QALY or incremental cost per point improvement in 
RMDQ. Bootstrapping will be used to calculate cost-effectiveness acceptability curves 
(CEACs). These will illustrate the effect of uncertainty on study results. Major assumptions 
made in the analysis will be tested by means of sensitivity analysis. In particular, assumptions 
made during the costing of the intervention such as the number of individuals who will be using 
the website will be explored. Similar methods to the main clinical analysis will be used to 
handle missing data, i.e., analysis of patterns of missing data with multiple imputation methods 
employed if deemed appropriate. The proposed health economics analysis will be detailed in a 
health economics analysis plan (HEAP) which will be completed before analysis commences. 
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The HEAP will be circulated for comment prior to the health economics analysis. Any 
digressions from the HEAP will be documented and justified in the final health economics 
report.  
 
Process evaluation 
A process evaluation will be carried out following Medical Research Council (MRC) guidelines 
on process evaluations of complex interventions. [42] In order to provide a detailed 
understanding of the SupportBack intervention three aspects will be examined: Implementation, 
mechanisms of impact (mediators) and context (moderators). A mixed methods approach will be 
used to explore these elements. 
 
Implementation 
Quantitative data describing trial implementation will be presented including number of 
practices recruited, patient eligibility [including reasons for declined participation where 
possible, and analysis of screen failures] and recruitment rates. The number of withdrawals from 
the trial per arm will be presented, along with numbers/percentages of dropouts from the 
intervention who do not respond to follow-up.  Use of the internet intervention will be described 
by presenting automated data collected on number of logins and modules accessed for both the 
internet intervention and the intervention plus telephone physiotherapist support arm. With 
regard to the internet intervention plus telephone physiotherapist support arm, the number of 
support calls successfully made (and attempts contact the patient), along with the mean number 
per participant in this arm will be described. 
 
Qualitative interviews will be conducted with up to 45 trial participants following the three, six 
and 12-month follow-up points. Different participants will be interviewed at each time point, 
enabling us to explore how time since accessing the tailored weekly component of the 
intervention effects how suggestions are used and implemented in daily life. Interviews will also 
be conducted with the trial physiotherapists. Participants will be purposively sampled to ensure 
diversity in terms of age, sex and symptom severity (physical function, pain intensity and 
duration).  Participants will also be sampled based on high and low usage of the internet 
intervention and high and low engagement with the telephone physiotherapist support. For 
participants, questions will focus on their experience of using the intervention, including 
telephone physiotherapist support and usual care. Interviews with the trial support 
physiotherapists will be designed to explore their experience of delivering the intervention, with 
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a particular focus on barriers and facilitators, and determinants of successful exchanges. 
 
Mechanisms of impact 
A logic model of proposed mechanisms affecting LBP-related physical disability and pain 
outcomes for the SupportBack intervention has been developed (see [14]). This model will be 
used as the basis of both quantitative and qualitative exploration of mechanisms. Quantitative 
analyses will focus on psychological and behavioural mechanisms influencing outcome 
following use of the interventions including expectancy, self-efficacy to manage LBP, physical 
activity, self-reported goal setting across the intervention and objective measures of intervention 
use (sessions completed, use of additional modules, e.g. mood, sleep etc.). In order to explore 
whether two core mechanisms’ [mediating variables] contribution to outcome is unique to the 
internet intervention arms, brief single items capturing self-efficacy (SE) and physical activity 
(PA) are being measured in all three arms (including usual care). SE and PA are being measured 
at baseline and in the outcome questionnaire sets at six weeks, three, six, and 12 months.  
Mediation analysis will be used to explore relationships between mediating variables and LBP-
related physical function and pain intensity across the 12-month follow-up period. We will also 
explore the potential of multilevel modelling to examine mediating variables association with 
the outcome over time. [43]  Appropriate checks of the assumptions of causal modelling, such 
as exchangeability (no confounding), consistency, effect modification and temporality will also 
be carried out. [44, 45] 
 
 
Questions will be included in the qualitative interviews focusing on participants’ perceptions of 
how use of the SupportBack intervention and/or telephone support affected their LBP. This will 
enable the inductive exploration of participants’ views and triangulation of qualitatively derived 
theory on mechanism with our quantitative analysis. Similar questions will also be explored in 
the usual care arm, focusing on how elements of their usual care may have led to improvements 
in their LBP. 
 
Context 
The relationship between elements of participants’ context [moderators] and the effect of the 
interventions across the 12-month follow-up period will be explored. This will include variables 
such as LBP severity and duration at baseline, age, educational level and occupation status. 
Following the analysis of mechanisms, correlations and multiple regression (linear and logistic) 
 18 
will be used to explore relationships between moderating variables and LBP-related physical 
function and pain intensity. Qualitatively, the above aspects of participants’ context, including 
their own descriptions of their LBP history, will feed into analysis when exploring themes 
regarding participants use of the intervention and their perceptions of benefit. [46]  
 
Qualitative analysis 
Interview data collected regarding implementation, mechanisms and context will be transcribed 
verbatim, coded and analysed using an inductive thematic analytic approach. [47, 48] This will 
ensure participants’ qualitative data are not constrained by the direction of a particular 
theoretical model, and enable novel insights from qualitative work to be added into the theory-
driven logic model. A key aspect of the qualitative analysis will entail exploring differences in 
accounts at different time points. This will enable us explore how time since the tailored weekly 
sessions impacts on the process of self-management.   
 
 
Data monitoring and confidentiality 
The SupportBack 2 trial has a data monitoring and ethics committee (DMEC) composed of a 
statistician (chair) and two academic clinicians (Professor in Primary Care Research and 
Professor of Physiotherapy respectively). The DMEC reports to the Trial Steering Committee 
(TSC) and is fully independent from the trial Sponsor with no competing interests. Interim 
descriptive analyses are prepared for the DMEC. The DMEC charter can be obtained from the 
research team on request.  
 
All Serious Adverse Events (SAEs) are reported to the lead Clinical Trial Unit (CTU). The 
assessment of seriousness will be made by the participants GP or delegate. Assessment of 
causality will be made by the GP or delegate, and related or unrelated status will be determined. 
As the SupportBack intervention provides reassurance and encourages gentle activity within the 
participants’ own limits, there are no ‘expected’ SAEs documented. 
All patient data are being kept in strict confidence and managed in accordance with the Data 
Protection Act 2018 and General Data Protection Regulation (GDPR 2018) legislation. The 
University of Southampton policy on archiving will be followed; the data will be stored for 10 
years following the end of the study, after which time it will be disposed of securely. Following 
completion of the trial, a cleaned anonymised data set will be shared on request.  
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Patient and public involvement (PPI) 
Patient representatives have been involved with the SupportBack trials from the outset. The idea 
for the trials and their subsequent design was informed by the local branch of the national 
charity BackCare. From this group, LL joined the research team and contributed to funding 
applications for both feasibility and main trials. SupportBack 2 has a panel of three PPI 
representatives who are part of the trial management group (TMG), advising on patient facing 
materials and contributing to discussions of trial related issues as they arise. PPI will pay a key 
role in dissemination of trial findings and interpretation of qualitative data.  
 
Ethics and dissemination 
The SupportBack 2 trial has received full ethical approval form a local review board (REC Ref: 
18/SC/0388). All potentially eligible patients receive a patient information sheet. This 
information emphasises that participation in the trial is voluntary and that the participant may 
withdraw from the trial at any time for any reason. The participants are given the opportunity to 
ask any questions that may arise by speaking with the trial team and time to consider the 
information fully prior to agreeing to participate. 
 
The findings of this trial will be published in peer reviewed journals and presented at 
international conferences. We will develop press releases in order to disseminate the findings to 
the general public, and work closely with our PPI collaborators to ensure dissemination to 
patient and other special interest groups. A summary of the findings will be sent to all included 
general practices and those patients that request this information. If the intervention is shown to 
be effective, we will work with developers to rapidly develop a version for widescale 
dissemination and implementation.  
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FIGURE LEGEND 
 
Figure 1. Flow through the trial. 
